The 17th World Bispecific Summit

Biointron is pleased to announce our participation in the 17th World Bispecific Summit 2026, taking place September 15–17, 2026, in Boston, Massachusetts. 

The World Bispecific Summit is a focused industry forum dedicated to advancing the discovery, engineering, translation, and clinical development of bispecific, multispecific, and cell engager therapeutics. The 2026 meeting will bring together senior leaders from pharma and biotech to discuss next-generation molecular design, target selection, developability, therapeutic windows, and strategies for accelerating differentiated multi-target antibody programs. 

As bispecific and multispecific antibodies continue to gain momentum across oncology, immunology, and other therapeutic areas, the event provides an important platform for discussing how innovative antibody formats can be designed, optimized, and advanced toward clinical success. 

Biointron looks forward to connecting with partners, collaborators, and industry peers in Boston and engaging in discussions that are shaping the future of bispecific and multispecific antibody therapeutics. 

For more details about the event, please visit the 17th World Bispecific Summit website [https://bispecific.com/] 

Time: September 15 - 17, 2026 

Location: The Westin Boston Seaport District | Boston, MA 

Booth: TBD